Click for best price
Prostate Cancer Diagnostics Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics and Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics and Therapy. This report contains market size and forecasts of Prostate Cancer Diagnostics and Therapy in global, including the following market information:
Global Prostate Cancer Diagnostics and Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Diagnostics and Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Androgen Receptor-Directed Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Diagnostics and Therapy include Ipsen SA, Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Abbvie Inc., Merck & Co. Inc., AstraZeneca PLC, Thermo Fisher Scientific and Dendreon Pharmaceuticals LLC, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Diagnostics and Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnostics and Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Diagnostics and Therapy Market Segment Percentages, by Type, 2022 (%)
Androgen Receptor-Directed Therapy
Taxane-Based Chemotherapy
Global Prostate Cancer Diagnostics and Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Diagnostics and Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Prostate Cancer Diagnostics and Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Prostate Cancer Diagnostics and Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnostics and Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Diagnostics and Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ipsen SA
Pfizer Inc.
Johnson & Johnson Services Inc.
Bayer AG
Abbvie Inc.
Merck & Co. Inc.
AstraZeneca PLC
Thermo Fisher Scientific
Dendreon Pharmaceuticals LLC
F. Hoffmann-La Roche Ltd
Hologic Inc.
Astellas Pharma Inc.
Koninklijke Philips NV
Sanofi-Aventis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Diagnostics and Therapy, market overview.
Chapter 2: Global Prostate Cancer Diagnostics and Therapy market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics and Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Diagnostics and Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Diagnostics and Therapy Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics and Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics and Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics and Therapy Overall Market Size
2.1 Global Prostate Cancer Diagnostics and Therapy Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Diagnostics and Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics and Therapy Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics and Therapy Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics and Therapy Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics and Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Diagnostics and Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics and Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Diagnostics and Therapy Market Size Markets, 2022 & 2029
4.1.2 Androgen Receptor-Directed Therapy
4.1.3 Taxane-Based Chemotherapy
4.2 By Type - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Diagnostics and Therapy Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnostics and Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue, 2024-2029
5.2.3 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnostics and Therapy Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnostics and Therapy Revenue, 2018-2029
6.3.2 US Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.3 France Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue, 2018-2029
6.5.2 China Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.5.6 India Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnostics and Therapy Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
7 Prostate Cancer Diagnostics and Therapy Companies Profiles
7.1 Ipsen SA
7.1.1 Ipsen SA Company Summary
7.1.2 Ipsen SA Business Overview
7.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.1.4 Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.1.5 Ipsen SA Key News & Latest Developments
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Company Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.2.4 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.2.5 Pfizer Inc. Key News & Latest Developments
7.3 Johnson & Johnson Services Inc.
7.3.1 Johnson & Johnson Services Inc. Company Summary
7.3.2 Johnson & Johnson Services Inc. Business Overview
7.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.3.4 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Services Inc. Key News & Latest Developments
7.4 Bayer AG
7.4.1 Bayer AG Company Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.4.4 Bayer AG Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.4.5 Bayer AG Key News & Latest Developments
7.5 Abbvie Inc.
7.5.1 Abbvie Inc. Company Summary
7.5.2 Abbvie Inc. Business Overview
7.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.5.4 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.5.5 Abbvie Inc. Key News & Latest Developments
7.6 Merck & Co. Inc.
7.6.1 Merck & Co. Inc. Company Summary
7.6.2 Merck & Co. Inc. Business Overview
7.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.6.4 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.6.5 Merck & Co. Inc. Key News & Latest Developments
7.7 AstraZeneca PLC
7.7.1 AstraZeneca PLC Company Summary
7.7.2 AstraZeneca PLC Business Overview
7.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.7.4 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca PLC Key News & Latest Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Company Summary
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.8.4 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.8.5 Thermo Fisher Scientific Key News & Latest Developments
7.9 Dendreon Pharmaceuticals LLC
7.9.1 Dendreon Pharmaceuticals LLC Company Summary
7.9.2 Dendreon Pharmaceuticals LLC Business Overview
7.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.9.4 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.9.5 Dendreon Pharmaceuticals LLC Key News & Latest Developments
7.10 F. Hoffmann-La Roche Ltd
7.10.1 F. Hoffmann-La Roche Ltd Company Summary
7.10.2 F. Hoffmann-La Roche Ltd Business Overview
7.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.10.4 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.10.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.11 Hologic Inc.
7.11.1 Hologic Inc. Company Summary
7.11.2 Hologic Inc. Business Overview
7.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.11.4 Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.11.5 Hologic Inc. Key News & Latest Developments
7.12 Astellas Pharma Inc.
7.12.1 Astellas Pharma Inc. Company Summary
7.12.2 Astellas Pharma Inc. Business Overview
7.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.12.4 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.12.5 Astellas Pharma Inc. Key News & Latest Developments
7.13 Koninklijke Philips NV
7.13.1 Koninklijke Philips NV Company Summary
7.13.2 Koninklijke Philips NV Business Overview
7.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.13.4 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.13.5 Koninklijke Philips NV Key News & Latest Developments
7.14 Sanofi-Aventis
7.14.1 Sanofi-Aventis Company Summary
7.14.2 Sanofi-Aventis Business Overview
7.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.14.4 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.14.5 Sanofi-Aventis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Diagnostics and Therapy Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnostics and Therapy Market Drivers in Global Market
Table 3. Prostate Cancer Diagnostics and Therapy Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnostics and Therapy in Global Market
Table 5. Top Prostate Cancer Diagnostics and Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Diagnostics and Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Diagnostics and Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Diagnostics and Therapy Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnostics and Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Prostate Cancer Diagnostics and Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Diagnostics and Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Prostate Cancer Diagnostics and Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Diagnostics and Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Ipsen SA Company Summary
Table 31. Ipsen SA Prostate Cancer Diagnostics and Therapy Product Offerings
Table 32. Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Ipsen SA Key News & Latest Developments
Table 34. Pfizer Inc. Company Summary
Table 35. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 36. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Inc. Key News & Latest Developments
Table 38. Johnson & Johnson Services Inc. Company Summary
Table 39. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 40. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Services Inc. Key News & Latest Developments
Table 42. Bayer AG Company Summary
Table 43. Bayer AG Prostate Cancer Diagnostics and Therapy Product Offerings
Table 44. Bayer AG Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer AG Key News & Latest Developments
Table 46. Abbvie Inc. Company Summary
Table 47. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 48. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Abbvie Inc. Key News & Latest Developments
Table 50. Merck & Co. Inc. Company Summary
Table 51. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 52. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Merck & Co. Inc. Key News & Latest Developments
Table 54. AstraZeneca PLC Company Summary
Table 55. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Product Offerings
Table 56. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. AstraZeneca PLC Key News & Latest Developments
Table 58. Thermo Fisher Scientific Company Summary
Table 59. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Product Offerings
Table 60. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Thermo Fisher Scientific Key News & Latest Developments
Table 62. Dendreon Pharmaceuticals LLC Company Summary
Table 63. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Product Offerings
Table 64. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Dendreon Pharmaceuticals LLC Key News & Latest Developments
Table 66. F. Hoffmann-La Roche Ltd Company Summary
Table 67. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Product Offerings
Table 68. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 70. Hologic Inc. Company Summary
Table 71. Hologic Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 72. Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Hologic Inc. Key News & Latest Developments
Table 74. Astellas Pharma Inc. Company Summary
Table 75. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 76. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Astellas Pharma Inc. Key News & Latest Developments
Table 78. Koninklijke Philips NV Company Summary
Table 79. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Product Offerings
Table 80. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Koninklijke Philips NV Key News & Latest Developments
Table 82. Sanofi-Aventis Company Summary
Table 83. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Product Offerings
Table 84. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Sanofi-Aventis Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Diagnostics and Therapy Segment by Type in 2022
Figure 2. Prostate Cancer Diagnostics and Therapy Segment by Application in 2022
Figure 3. Global Prostate Cancer Diagnostics and Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnostics and Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnostics and Therapy Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
Figure 16. US Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
Figure 28. China Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer AG Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
